Usefulness of carotid ultrasonography in the evaluation of the effectiveness of hypolipidemic therapy;Utilidad de la ecografía carotídea en la evaluación de la eficacia terapéutica del tratamiento hipolipemiante

Medicina Clinica

Volumn 133, Issue 4, 2009, Pages 135-136

  Junyent, Mireia ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; PRAVASTATIN; RIMONABANT; ROSUVASTATIN; SIMVASTATIN; TORCETRAPIB;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFECT; DYSLIPIDEMIA; ECHOGRAPHY; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPOLIPEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION;

CAROTID ARTERIES; HUMANS; HYPOLIPIDEMIC AGENTS; TUNICA INTIMA; TUNICA MEDIA;

EID: 68149171951     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.04.008     Document Type: Article

References (17)

1. E. De Groot, K. Hovingh, A. Wiegman, P. Duriez, A.J. Smith, and J.C. Fruchart Measurement of arterial wall thickness as a surrogate marker for atherosclerosis Circulation 109 2004 33 38
2. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, and M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness. A systematic review and meta-analysis Circulation 115 2007 459 467
3. J.J. Kastelein, and E. De Groot Ultrasound imaging techniques for the evaluation of cardiovascular therapies Eur Heart J 29 2008 849 858
4. T.J. Smilde, S. Van Wissen, H. Wollersheim, M.D. Trip, J.J. Kastelein, and A.F. Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial Lancet 357 2001 577 581
5. S. Van Wissen, T.J. Smilde, M.D. Trip, A.F.H. Stalenhoef, and J.J. Kastelein Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia Am J Cardiol 95 2005 264 266
6. A.J. Taylor, S.M. Kent, P.J. Flaherty, L.C. Coyle, T.T. Markwood, and M.N. Vernalis ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol. A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation 106 2002 2055 2060
7. J.R. Crouse 3rd, J.S. Raichlen, W.A. Riley, G.W. Evans, M.K. Palmer, and D.H. O'leary Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: The METEOR Trial JAMA 297 2007 1344 1353
8. W.P. Castelli, R.J. Garrison, P.W. Wilson, R.D. Abbott, S. Kalousdian, and W.B. Kannel Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study JAMA 256 1986 2835 2838
9. A.J. Taylor, L.E. Sullenberger, H.J. Lee, J.K. Lee, and K.A. Grace Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients with statins Circulation 110 2004 3512 3517
10. J.J. Kastelein, S.I. Van Leuven, L. Burgess, G.W. Evans, J.A. Kuivenhoven, and P.J. Barter Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia N Engl J Med 356 2007 1620 1630
11. M.L. Bots, F.L. Visseren, G.W. Evans, W.A. Riley, J.H. Revkin, and C.H. Tegeler Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): A randomised, double-blind trial Lancet 370 2007 153 160
12. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, and M. Komajda Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
13. J.J.P. Kastelein, F. Akdim, E. Stroes, A.H. Zwinderman, M.L. Bots, and A. Stalenhoef Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
14. J.L. Fleg, M. Mete, B.V. Howard, J.G. Umans, M.J. Roman, and R.E. Ratner Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes. The SANDS (Stop Atherosclerosis in Native Diabetics Study) Trial J Am Coll Cardiol 52 2008 2198 2205
15. Lahoz C, Mostaza JM, San Martín MA, García Iglesias MF, Frías M, García A, et al. Grosor de la íntima media carotídea en la hipercolesterolemia familiar heterocigota: Factores asociados y variación al año de tratamiento. Med Clin. doi:10.1016/j.medcli.2009.02.052.
16. T. Simon, P. Boutouyrie, A. Gompel, S. Christin-Maitre, S. Laurent, C. Thuillez on behalf of the CASHMERE Investigators Rationale, design and methods of the CASHMERE study Fundam Clin Pharmacol 18 2004 131 138
17. M. Junyent, and E. Ros ¿Son necesarios los estudios angiográficos para valorar la eficacia del tratamiento hipolipidemiante? Clin Invest Arterioscler 17 2005 7 15